Humana Reaffirms FY26 Adjusted EPS Guidance Of At Least $9; Exceeding Goal Of Top Quartile Results In 2027 Medicare Advantage Star Ratings; Expects 2028 Benefit For One-Time Investments And Return To Shareholders

Humana has reaffirmed its guidance for fiscal year 2026, projecting adjusted earnings per share (Adjusted EPS) of at least $9.00. This guidance aligns with previous announcements made on July 29, 2026, and confirmed in a recent SEC filing. The company is currently finalizing its financial results for the third quarter of 2026 and anticipates potential adjustments to its GAAP EPS guidance, although it does not expect changes to its Adjusted EPS guidance.